← Back to Clinical Trials
Recruiting NCT06796309

NCT06796309 Assessment of Rural Health Care: Implementing TRAK Digital Tool for Quality and Accessible Services

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06796309
Status Recruiting
Phase —
Sponsor Trak Health Solutions S.L.
Condition Shoulder Pain
Study Type INTERVENTIONAL
Enrollment 95 participants
Start Date 2024-02-07
Primary Completion 2025-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Trak Telerehabilitation PlatformConventional Rehabilitation Program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 95 participants in total. It began in 2024-02-07 with a primary completion date of 2025-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This clinical trial aims to analyze the usability and degree of satisfaction of two populations, healthcare personnel (Population 1) in rural areas and their patients (Population 2), with the TRAK tele-rehabilitation tool. Participants will undergo telerehabilitation treatment through the TRAK platform for eight weeks (treatment group) or follow an at home exercise protocol (control group).

Eligibility Criteria

Inclusion Criteria population 1: * They carry out their activity in a rural environment. * That they know how to use the tool. * That they have a device with which to use the tool. * That they have an e-mail address. * That they have an Internet connection. * That they have signed the informed consent form. Exclusion Criteria population 1: * N/A Inclusion Criteria population 2: * Seniors. * Patients with omalgia of more than 6 months of evolution. * Who have a device with which to use the tool. * Who have a device with which to use the tool. * Who have an Internet connection. * Who have an e-mail address. * Who have signed the informed consent form. Exclusion Criteria population 2: * Patients with cognitive impairment.

Contact & Investigator

Central Contact

JUAN F DUARTE MENDOZA

✉ juanfernando@trak.es

📞 +34 677 33 4869

Principal Investigator

ANA VADILLO CORTÁZAR

PRINCIPAL INVESTIGATOR

Hospital Universitario del Sureste

Frequently Asked Questions

Who can join the NCT06796309 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06796309 currently recruiting?

Yes, NCT06796309 is actively recruiting participants. Contact the research team at juanfernando@trak.es for enrollment information.

Where is the NCT06796309 trial being conducted?

This trial is being conducted at Madrid, Spain.

Who is sponsoring the NCT06796309 clinical trial?

NCT06796309 is sponsored by Trak Health Solutions S.L.. The principal investigator is ANA VADILLO CORTÁZAR at Hospital Universitario del Sureste. The trial plans to enroll 95 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology